Aminoglycosides Antibiotics Market, Global Outlook and Forecast 2023-2029

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.
This report aims to provide a comprehensive presentation of the global market for Aminoglycosides Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aminoglycosides Antibiotics. This report contains market size and forecasts of Aminoglycosides Antibiotics in global, including the following market information:
Global Aminoglycosides Antibiotics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Aminoglycosides Antibiotics Market Sales, 2018-2023, 2024-2029, (M Units)
Global top five Aminoglycosides Antibiotics companies in 2022 (%)
The global Aminoglycosides Antibiotics market was valued at US$ 1081.9 million in 2022 and is projected to reach US$ 1268.3 million by 2029, at a CAGR of 2.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The classification of Aminoglycosides Antibiotics includes Neomycin, Tobramycin, Gentamicin, Amikacin, Etimicin and Others. In addition, the proportion of Neomycin in 2019 is about 26%, and Etimicin mainly sales in China.
Aminoglycosides Antibiotics is widely used for Hospital, Clinic, Post Care Facility, Government & Military and Others. The most proportion of Aminoglycosides Antibiotics is for clinic, and the proportion in 2019 is about 35%. 
Europe is the largest consumption place, with a consumption market share nearly 26% in 2019. Following Europe, China is the second largest consumption place with the consumption market share of about 16%. 
Jemicare, Teva, Novartis Pharmaceuticals, Fangyuan-pharma, Aike Pharmaceutical, Cipla, etc. are the leaders of the industry.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Aminoglycosides Antibiotics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Aminoglycosides Antibiotics Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Aminoglycosides Antibiotics Market Segment Percentages, by Type, 2022 (%)
    Neomycin
    Tobramycin
    Gentamicin
    Amikacin
    Etimicin
    Others
Global Aminoglycosides Antibiotics Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Aminoglycosides Antibiotics Market Segment Percentages, by Application, 2022 (%)
    Hospital
    Clinic
    Post Care Facility
    Government & Military
    Others
Global Aminoglycosides Antibiotics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Aminoglycosides Antibiotics Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Aminoglycosides Antibiotics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Aminoglycosides Antibiotics revenues share in global market, 2022 (%)
Key companies Aminoglycosides Antibiotics sales in global market, 2018-2023 (Estimated), (M Units)
Key companies Aminoglycosides Antibiotics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Jemicare
    Teva
    Novartis
    Fangyuan-pharma
    Aike Pharmaceutical
    Cipla
    Pfizer
    Fresenius Kabi
    Sun Pharma
    Hikma
    Lannett Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Aminoglycosides Antibiotics, market overview.
Chapter 2: Global Aminoglycosides Antibiotics market size in revenue and volume.
Chapter 3: Detailed analysis of Aminoglycosides Antibiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Aminoglycosides Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Aminoglycosides Antibiotics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.